Novita Healthcare Limited, formerly Avexa Limited, is a medical technology company. The Company is involved in research and development, for commercialization, of pharmaceutical programs and medical technology projects. The Company's segments include Research and Development, and Investments. The Research and Development segment is engaged in the operation of conducting health and medical research and development for commercialization. The Investments segment is engaged in investing excess funds in approved instruments, including the United States coal mine and Australian equities. The Company offers TALI, an early identification and intervention program. The computerized program continuously adapts to the child's performance to challenge and sharpen their attention skills. TALI provides access to deeper analytics about the child's individual performance on each of the exercises, allowing parents, educators and clinicians to identify areas of attentional strengths and weaknesses.